US Nuclear CORP
Market Movers (8-K)
OTC.Pink
UCLE
US Nuclear CORPUS Nuclear Corp announced the immediate resignation of Director Michael Pope, effective April 16, 2026, to pursue other opportunities.
OTC.Pink
UCLE
US Nuclear CORPUS Nuclear Corp has replaced its independent registered public accounting firm, Fruci & Associates II, PLLC, with Simon & Edward, LLP, effective October 29, 2025.
Worse than expected
OTC.Pink
UCLE
US Nuclear CORPUS Nuclear Corp announced a change in its independent registered public accounting firm, dismissing Fruci & Associates II, PLLC and engaging Simon & Edward, LLP, effective October 29, 2025.
OTC.Pink
UCLE
US Nuclear CORPUS Nuclear Corp has reinstated Michael Pope as a director after a brief period of removal due to a miscommunication.
OTC.Pink
UCLE
US Nuclear CORPUS Nuclear Corp has revoked the board membership of Michael Pope due to his lack of communication and unresponsiveness.
Worse than expected
Quarterly Earnings (10-Q)
OTC.Pink
UCLE
US Nuclear CORPUS Nuclear Corp. reported a reduced net loss for the nine months ended September 30, 2025, driven by one-time settlement income, but faces substantial doubt about its ability to continue as a going concern.
Worse than expected
Capital raise
OTC.Pink
UCLE
US Nuclear CORPUS Nuclear Corp. reported an 18.3% decline in sales and a 24.4% increase in net loss for the first half of 2025, raising substantial doubt about its ability to continue as a going concern.
Worse than expected
Capital raise
OTC.Pink
UCLE
US Nuclear CORPUS Nuclear Corp. reported a significant net loss and revenue decline in Q1 2025, raising going concern doubts while disclosing ineffective disclosure controls.
Capital raise
Worse than expected
OTC.Pink
UCLE
US Nuclear CORPUS Nuclear Corp's Q3 2024 results show a slight revenue increase and reduced net loss, alongside significant debt restructuring and the introduction of Series A Preferred Stock.
Better than expected
Capital raise
OTC.Pink
UCLE
US Nuclear CORPUS Nuclear Corp. saw a significant increase in sales during the second quarter of 2024, but the company still reported a net loss.
Worse than expected
Capital raise
OTC.Pink
UCLE
US Nuclear CORPUS Nuclear Corp. reports a net loss of $161,978 for the first quarter of 2024, an improvement compared to the $664,534 loss in the same period of 2023.
Better than expected
Capital raise
Annual Reports (10-K)
OTC.Pink
UCLE
US Nuclear CORPUS Nuclear Corp. (UCLE) reported a significant reduction in its net loss for fiscal year 2024, driven by improved gross margins and lower other expenses, despite facing substantial doubt about its ability to continue as a going concern and acknowledging ineffective internal controls.
Capital raise
Better than expected
OTC.Pink
UCLE
US Nuclear CORPUS Nuclear Corp.'s annual report reveals a revenue increase of 6.68% in 2023, but also a significant widening of net losses compared to the previous year.
Capital raise
Worse than expected